James Pepka, DO
Family Medicine · Auburn, WANPI 1821136086
Payments from drug & device makers
Across 46 payments — averaging $18.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$167
- Teva Pharmaceuticals USA, Inc.$106
- Daiichi Sankyo Inc.$87
- Pfizer$67
- Novartis$58
- AstraZeneca$47
- plus $328 from 13 others
What the payments were for
- Food & beverage$860100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 8 | $167 |
| Teva Pharmaceuticals USA, Inc. | 5 | $106 |
| Daiichi Sankyo Inc. | 4 | $87 |
| Pfizer | 4 | $67 |
| Novartis | 3 | $58 |
| AstraZeneca | 3 | $47 |
| Biohaven Pharmaceuticals, Inc. | 2 | $40 |
| Lilly USA, LLC | 2 | $36 |
| Ironwood Pharmaceuticals, Inc | 2 | $36 |
| Hikma Pharmaceuticals USA | 2 | $35 |
| Mylan Specialty L.p. | 2 | $30 |
| Amgen(2 entities) | 2 | $26 |
| Bristol Myers Squibb | 1 | $23 |
| Amarin Pharma, Inc. | 1 | $22 |
| Esperion Therapeutics, Inc. | 1 | $20 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $17 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
| Upsher-smith Laboratories LLC | 1 | $13 |
| Eisai Inc. | 1 | $13 |
How this compares
$860 in reported general payments places this provider in the 80th percentile of 2,275 family medicine providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 40 | $462 |
| Levothyroxine Sodium | 22 | $397 |
| Lisinopril | 35 | $287 |
| Amlodipine Besylate | 39 | $238 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 13 | $202 |
| Metoprolol Succinate | 28 | $190 |
| Montelukast Sodium | 15 | $175 |
| Doxycycline Hyclate | 14 | $142 |
| Pantoprazole Sodium | 11 | $138 |
| Trazodone Hcl | 11 | $120 |
| Rosuvastatin Calcium | 13 | $100 |
| Metformin Hcl | 11 | $99 |
| Hydrochlorothiazide | 11 | $71 |
| Sertraline Hcl | 11 | $65 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Auburn
- Steven SmithAuburn$438K
- Asra KhanAuburn$26K
- Anton GraschWenatchee$5.3M
- Gaylon KippBellevue$4.8M
- Steven KasterWenatchee$4M
- Angela EakinSpokane$3M
- Jonathan StabenCheney$2.5M
- Emily ZaragozaSeattle$1.9M
- Brad FrandsenPort Orchard$1.7M
- Kevin HatfieldSeattle$527K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.